Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nicholas B. Miner"'
Publikováno v:
J Pharmacol Exp Ther
Methamphetamine (MA) impairs vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function and expression, increasing intracellular DA levels that lead to neurotoxicity. The trace amine–associated receptor 1 (TAAR1) is activated
Publikováno v:
Drug and Alcohol Dependence. 227:108974
Background High doses of the synthetic opioid fentanyl cause rapid and sustained vocal cord closure (VCC) leading to airway obstruction that prevents overdose victims from breathing. This airway effect is not caused by morphine-derived opiates (e.g.
Publikováno v:
NeuroToxicology. 63:57-69
Trace amine-associated receptor 1 (TAAR1) is activated by methamphetamine (MA) and modulates dopaminergic (DA) function. Although DA dysregulation is the hallmark of MA-induced neurotoxicity leading to behavioral and cognitive deficits, the intermedi
Publikováno v:
Neurotoxicology and Teratology. 61:74-81
The rise in popularity of substituted methcathinones (aka “bath salts”) has increased the focus on their neurotoxic effects. Two commonly abused methcathinones, 3,4-methylenedioxymethcathinone (methylone, MDMC) and 3,4-methylenedioxypyrovalerone
Publikováno v:
Genes Brain Behav
Mice selectively bred for high methamphetamine (MA) drinking (MAHDR), compared to mice bred for low MA drinking (MALDR), exhibit greater sensitivity to MA reward and insensitivity to aversive and hypothermic effects of MA. Previous work identified th
Methamphetamine (MA) is highly addictive and neurotoxic, causing cell death in humans and in rodent models. MA, along with many of its analogs, is an agonist at the G protein-coupled trace amine-associated receptor 1 (TAAR1). TAAR1 activation protect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db606ac5cb00b619f8b8b6d61d0ebf7e
https://europepmc.org/articles/PMC6744391/
https://europepmc.org/articles/PMC6744391/